News

Baxdrostat is a highly selective, second-generation, nonimidazole aldosterone synthase inhibitor; 100 times less baxdrostat ...
Tempus AI surges 91.8% YTD with soaring genomics revenues and a $200M AstraZeneca deal, outpacing NVIDIA in AI healthcare gains.
"While U.S. POINTER was designed and powered as a head-to-head comparison of the two interventions, and a statistically ...
President Trump, meeting with Britain’s prime minister in Scotland, called on Russia to stop its attacks in Ukraine in less ...
French MBE company Riber has reported its results for the first half of 2025 with revenues of €10.7m, down 22 percent ...